SelectiveM3muscarinicreceptorantagonist(pKivaluesare8.52,7.93,7.90and7.78forM3,M2,M1andM4receptorsrespectively).DisplayshigheraffinityatilealM3receptors(pKi=9.3)comparedtooesophagealandtrachealM3receptors(pKivaluesare8.8and8.2respectively).Inhibitsgastrointestinalmotilityinvivointheabsenceofcardiovasculareffects.
ZamifenacinfumarateisalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
| M.Wt | 531.6 |
| Formula | C27H29NO3.C4H4O4 |
| Storage | Desiccateat+4°C |
| Purity | ≥99%(HPLC) |
| CASNumber | 127308-98-9 |
| PubChemID | 20056967 |
| InChIKey | PMHKTAIGYOVZEZ-ZHWJIHCSSA-N |
| Smiles | C1(CCN3C[C@H](OC(C5=CC=CC=C5)C4=CC=CC=C4)CCC3)=CC=C(OCO2)C2=C1.C(C=CC(O[H])=O)(O[H])=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 53.16 | 100 | |
| ethanol | 13.29 | 25 |
Thefollowingdataisbasedontheproductmolecularweight531.6.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 1.88mL | 9.41mL | 18.81mL |
| 5mM | 0.38mL | 1.88mL | 3.76mL |
| 10mM | 0.19mL | 0.94mL | 1.88mL |
| 50mM | 0.04mL | 0.19mL | 0.38mL |